PubRank

Casper Schalkwijk

Author PubWeight™ 16.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011 2.16
2 Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2003 1.75
3 Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria. Diabetes Care 2009 1.33
4 Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy. Diabetes 2008 1.11
5 Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure. Kidney Int 2005 1.06
6 C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification. Diabetes Care 2002 1.03
7 Severe hypoglycemia and cardiovascular disease incidence in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2012 0.96
8 NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α. Diabetes Care 2012 0.94
9 Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy. Diabetes 2006 0.93
10 Stability of soluble adhesion molecules, selectins, and C-reactive protein at various temperatures: implications for epidemiological and large-scale clinical studies. Clin Chem 2007 0.86
11 The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction. Am Heart J 2012 0.84
12 Dose-finding study of the multitargeted tyrosine kinase inhibitor SU6668 in patients with advanced malignancies. Clin Cancer Res 2005 0.84
13 N epsilon-(carboxymethyl)lysine during the early development of hypertension. Ann N Y Acad Sci 2007 0.84
14 Anti-heat shock protein 27 antibody levels and diabetes complications in the EURODIAB study. Diabetes Care 2009 0.81
15 Preparation of advanced glycation end products in vitro. Nephrol Dial Transplant 2007 0.80
16 Distinct accumulation patterns of soluble forms of E-selectin, VCAM-1 and ICAM-1 upon infusion of TNFalpha in tumor patients. Thromb Haemost 2003 0.79